Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2− Early Breast Cancer

BACKGROUND: The prognostic or predictive value of commonly used multigene assays in young patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) early breast cancer is unclear. In this study, we assessed the prognostic value of the GenesWell BCT assa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Mi Jeong, Ryu, Jai Min, Cho, Soo Youn, Nam, Seok Jin, Kim, Seok Won, Lee, Jeeyeon, Lee, Soo Jung, Park, Ji-Young, Park, Ho Yong, Hong, Sungjun, Kim, Kyunga, Han, Jinil, Moon, Youngho, Shin, Young Kee, Lee, Jeong Eon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942224/
https://www.ncbi.nlm.nih.gov/pubmed/33708625
http://dx.doi.org/10.3389/fonc.2021.588728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942224/
https://www.ncbi.nlm.nih.gov/pubmed/33708625
http://dx.doi.org/10.3389/fonc.2021.588728

Ejemplares similares